C07C231/00 - CPC Classification Index

ClassID:

92711 ⎘

C07C231/00 - CPC Classification

Classification description:

Preparation of carboxylic acid amides

Sub-classes:

C07C231/02 » from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines 737
C07C231/04 » from ketenes by reaction with ammonia or amines 3
C07C231/06 » from nitriles by transformation of cyano groups into carboxamide groups 85
C07C231/08 » from amides by reaction at nitrogen atoms of carboxamide groups 57
C07C231/10 » from compounds not provided for in groups to 157
C07C231/12 » by reactions not involving the formation of carboxamide groups 794
C07C231/14 » by formation of carboxamide groups together with reactions not involving the carboxamide groups 203
C07C231/16 » Preparation of optical isomers 14
C07C231/22 » Separation; Purification; Stabilisation; Use of additives 49

Recent Application in this class:

20250320177

2025-10-16

COMPOUNDS AND METHODS FOR LIQUID PHASE OLIGONUCLEOTIDE SYNTHESIS

20250188116

2025-06-12

DEPROTECTION METHOD AND RESIN REMOVAL METHOD IN SOLID-PHASE REACTION FOR PEPTIDE COMPOUND OR AMIDE COMPOUND, AND METHOD FOR PRODUCING PEPTIDE COMPOUND

20250171712

2025-05-29

MACAÚBA OIL FOR THE PRODUCTION OF OLEOCHEMICALS

20240228433

2024-07-11

Compounds and methods for liquid phase oligonucleotide synthesis

20240132728

2024-04-25

Bio-Based Coalescing Solvents

20230303619

2023-09-28

DEPROTECTION METHOD AND RESIN REMOVAL METHOD IN SOLID-PHASE REACTION FOR PEPTIDE COMPOUND OR AMIDE COMPOUND, AND METHOD FOR PRODUCING PEPTIDE COMPOUND

20220306658

2022-09-29

METHOD OF PRODUCING L-GLUFOSINATE

20200253901

2020-08-13

STABLE DOSAGE FORMS OF LEVOMILNACIPRAN

20200031808

2020-01-30

Process for synthesis of eliglustat and intermediate compounds thereof

#10

20180215942

2018-08-02

Ionic liquid composition and method for dissolving cellulose using the same

#11

20180028476

2018-02-01

STABLE DOSAGE FORMS OF LEVOMILNACIPRAN

#12

20180022679

2018-01-25

Heterogeneous metal-free catalyst

#13

20170305838

2017-10-26

Continuous process for producing a surfactant in a tube reactor

#14

20170273933

2017-09-28

Anti-tumor compound and the medical use thereof

#15

20160176805

2016-06-23

Process for manufacturing haloacetamides

#16

20160152663

2016-06-02

Use of ruthenium complexes for preparing amides, polypeptides and cyclic dipeptides

#17

20160108067

2016-04-21

Method for producing fluorine-containing substituted compound and fluorine-containing substituted compound

#18

20150353464

2015-12-10

Heterogeneous metal-free catalyst

#19

20150284318

2015-10-08

Graphene quantum dots and method of making

#20

20150080472

2015-03-19

Treatment of friedreich's ataxia using histone deacetylase inhibitors

#21

20150038740

2015-02-05

Alanyl glutamine compound and preparation method thereof

#22

20150038587

2015-02-05

Crystalline forms of (1S,2R)-2-(amino methyl)-N,N-diethyl-1-phenyl cyclopropane carboxamide

#23

20140336252

2014-11-13

Compound as KCNQ potassium channel agonist, preparation method therefor and use thereof

#24

20140088158

2014-03-27

Acylamino-substituted cyclic carboxylic acid derivatives and their use as pharmaceuticals

#25

20140012027

2014-01-09

Method for producing fluorine-containing substituted compound and fluorine-containing substituted compound

#26

20130210919

2013-08-15

NOVEL CRYSTALLINE FORMS OF (1S,2R)-2-(AMINO METHYL)-N,N-DIETHYL-1-PHENYL CYCLOPROPANE CARBOXAMIDE

#27

20130210918

2013-08-15

Treatment of friedreich's ataxia using histone deacetylase inhibitors

#28

20130140495

2013-06-06

Method and system for producing graphene and functionalized graphene

#29

20130109856

2013-05-02

NOVEL PROCESS FOR THE PREPARATION OF ACYLGUANIDINES AND ACYLTHIOUREAS

#30

20130109752

2013-05-02

Derivative of 18β-glycyrrhetinic acid apt to suppress cancer cells

#31

20130085304

2013-04-04

PROCESSES FOR PREPARATION OF POLYMORPHIC FORMS OF LACOSAMIDE

#32

20130042615

2013-02-21

Advanced method and apparatus for addressing the serious pollution from existing coal-burning power stations

#33

20130032510

2013-02-07

Advanced method and apparatus to process Bitumen containing impurities

#34

20120264834

2012-10-18

Disodium salts, monohydrates, and ethanol solvates for delivering active agents

#35

20120264790

2012-10-18

Acylamino-substituted cyclic carboxylic acid derivatives and their use as pharmaceuticals

#36

20120253042

2012-10-04

Use of ruthenium complexes for formation and/or hydrogenation of amides and related carboxylic acid derivatives

#37

20110251125

2011-10-13

Disodium salts, monohydrates, and ethanol solvates for delivering active agents

#38

20110144210

2011-06-16

Stable dosage forms of levomilnacipran

#39

20110112197

2011-05-12

Crystalline forms of (1S,2R)-2-(amino methyl)-N,N-diethyl-1-phenyl cyclopropane carboxamide

#40

20110021562

2011-01-27

TREATMENT OF FRIEDREICH'S ATAXIA USING HISTONE DEACETYLASE INHIBITORS

#41

20100099621

2010-04-22

Disodium salts, monohydrates, and ethanol solvates for delivering active agents

#42

20090299098

2009-12-03

Catalytic metathesis of secondary amides

#43

20090112005

2009-04-30

Process for preparing amides from alcohols and amines

#44

20080269134

2008-10-30

Disodium salts, monohydrates, and ethanol solvates for delivering active agents

#45

20070293661

2007-12-20

Water-soluble group III polyether acid salt complexes and thin films from same

#46

20070219244

2007-09-20

Histone deacetylase inhibitors as therapeutics for neurological diseases

#47

20070059230

2007-03-15

Process

#48

15687181

2018-01-09

Method of N-formylating amines with a phosphonic anhydride

#49

15681716

2018-06-05

Process for synthesis of Eliglustat and intermediate compounds thereof